<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04610099</url>
  </required_header>
  <id_info>
    <org_study_id>NL70754.091.19</org_study_id>
    <nct_id>NCT04610099</nct_id>
  </id_info>
  <brief_title>Creating a Laparoscopic Banded Sleeve Gastrectomy</brief_title>
  <acronym>RING</acronym>
  <official_title>Creating a Laparoscopic Banded Sleeve Gastrectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rijnstate Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rijnstate Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Sleeve Gastrectomy (SG) is on the long term not always successful in every patient because&#xD;
      weight regain can occur. An intervention to prevent weight regain in the future is to place a&#xD;
      silicone band (non-adjustable) around the sleeve (Banded-Sleeve Gastrectomy: BSG) which&#xD;
      increases weight loss and decreases weight regain on the longer term. The question is whether&#xD;
      primary application of a banded sleeve gives a greater weight loss and / or prevent weight&#xD;
      regain in the future versus a standard sleeve gastrectomy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A Sleeve Gastrectomy (SG) is on the long term not always successful in every patient because&#xD;
      weight regain can occur. An intervention to prevent weight regain in the future is to place a&#xD;
      silicone band (non-adjustable) around the sleeve (Banded-Sleeve Gastrectomy: BSG) which&#xD;
      increases weight loss and decreases weight regain on the longer term. The question is whether&#xD;
      primary application of a banded sleeve gives a greater weight loss and / or prevent weight&#xD;
      regain in the future versus a standard sleeve gastrectomy.&#xD;
&#xD;
      Study is a prospective, randomized, multi centre trial.&#xD;
&#xD;
      Study population: patients who qualify for a SG are eligible to participate. The primary SG&#xD;
      patients may participate if there is a BMI of 35 kg / m2 with a morbidly obesity-related&#xD;
      comorbidity or a BMI of 40kg / m2 or higher.&#xD;
&#xD;
      Intervention: The standard SG is compared with a banded-SG (BSG)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">September 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage Total Body Weight loss (%TBWL)</measure>
    <time_frame>3 years</time_frame>
    <description>((preoperative weight - current weight) / (preoperative weight)) x 100%. Weight loss measured in kilograms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage Excess Weight Loss (%EWL)</measure>
    <time_frame>3 years</time_frame>
    <description>((Preoperative weight - current weight) / (preoperative weight - ideal weight at BMI 25)) x 100%. Weight loss measured in kilograms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life due to questionnaire</measure>
    <time_frame>3 years</time_frame>
    <description>Measuring BAROS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life due to questionnaire</measure>
    <time_frame>3 years</time_frame>
    <description>Measuring BODY-Q</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life due to questionnaire</measure>
    <time_frame>3 years</time_frame>
    <description>Measuring SF-36</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastroesophageal reflux disease</measure>
    <time_frame>3 years</time_frame>
    <description>Measuring GERD-HRQL questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of comorbidities</measure>
    <time_frame>3 years</time_frame>
    <description>Measuring reduction of diabetes, hypertension, dyslipidemia, osteoarticular disease, OSA</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Morbid Obesity</condition>
  <arm_group>
    <arm_group_label>Standard SG</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>100 patients undergo a standard sleeve gastrectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Banded SG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100 patients undergo a banded sleeve gastrectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Banded Sleeve Gastrectomy</intervention_name>
    <description>banded sleeve gastrectomy</description>
    <arm_group_label>Banded SG</arm_group_label>
    <other_name>BSG</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard SG</intervention_name>
    <description>Standard SG</description>
    <arm_group_label>Standard SG</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Alle patients who are eligible for a primary SG&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Bariatric surgery in medical history&#xD;
&#xD;
          -  BMI &gt; 60kg/m2 or a planned two-stage procedure.&#xD;
&#xD;
          -  Patients with a language barrier which may affect the compliance with medical advice&#xD;
&#xD;
          -  Patients with a disease not related to morbid obesity, such as Cushing or drug&#xD;
             related.&#xD;
&#xD;
          -  Chronic bowel disease for example Crohn's disease or colitis Colitis.&#xD;
&#xD;
          -  Renal impairment (MDRD &lt;30) or hepatic dysfunction (liver function twice the normal&#xD;
             values)&#xD;
&#xD;
          -  Pregnancy during follow-up&#xD;
&#xD;
          -  Patients with treatment-resistant reflux symptoms. Defined as reflux persistent&#xD;
             symptoms despite the use of a minimum dose of proton-pump inhibitors&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hazebroek</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rijnstate Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hazebroek, MD, PhD</last_name>
    <phone>+31880055970</phone>
    <email>info@vitalys.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rijnstate Hospital</name>
      <address>
        <city>Arnhem</city>
        <state>Gelderland</state>
        <zip>6815AD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hazebroek</last_name>
      <phone>0880055970</phone>
      <email>info@vitalys.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zuyderland Medisch Centrum</name>
      <address>
        <city>Heerlen</city>
        <state>Limburg</state>
        <zip>6419PC</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>E.G. Boerma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Antonius Ziekenhuis</name>
      <address>
        <city>Nieuwegein</city>
        <state>Utrecht</state>
        <zip>3435CM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wiezer</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 26, 2020</study_first_submitted>
  <study_first_submitted_qc>October 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2020</study_first_posted>
  <last_update_submitted>October 29, 2020</last_update_submitted>
  <last_update_submitted_qc>October 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

